References
- King A, Shannon K, Phillips I. The in vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. J Antimicrob Chemother 1984; 13: 325–331
- Shannon K, Phillips I. The antimicrobial spectrum of the quinolones. Clin Res Forum 1985; 7: 29–36
- van Caekenberghe D L, Pattyn S R. In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives. Antimicrob Agents Chemother 1984; 25: 518–521
- Chin N-X, Neu H C. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1984; 25: 319–326
- Barry A L, Jones R N. Cross resistance among cinoxacin, ciprofloxacin DJ-6783, enoxacin, nalidixic acid, norfloxacin and oxolinic acid after in vitro selection of resistant populations. Antimicrob Agents Chemother 1984; 25: 775–777
- Holdeman L V, Cato E P, Moore W EC. Anaerobic laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg 1977
- Dornbusch K, Nord C E, Wadström T. Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. Scand J Infect Dis 1974; 6: 253–258
- Wise R, Lockley M R, Crump B, Adhami Z N. The pharmacokinetics and tissue penetration of orally administered enoxacin, norfloxacin and ciprofloxacin. Clin Res Forum 1985; 7: 63–68
- Wise R, Lockley R M, Vebberly M, Dent J. Pharmacokinetics of intravenously administered ciprofloxacin. Antimicrob Agents Chemother 1984; 26: 208–210
- Bergan T, Delin C, Johansen S, Kolstad I M, Nord C E, Thorsteinsson S B. Stable steady state pharmacokinetics and the effect of ciprofloxacin on salivary and fecal microflora during repeated dosage. Antimicrob Agents Chemother, In press